{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:04:08Z","timestamp":1780448648003,"version":"3.54.1"},"reference-count":78,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Historically, craniopharyngioma (CP) was divided into adamantinomatous CP (ACP) and papillary CP (PCP) subtypes based on histopathological features. However, each harbors a unique genetic profile and progressively differing treatment paradigms, leading to their reclassification by the WHO in 2016 as two distinct entities. Descriptive in nature, this large multi-institutional study aimed to establish current differences between the presentation, treatment patterns, and clinical course of these pathologies to serve as a baseline for future studies as new treatment paradigms emerge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors queried the Registry for Adenomas of the Pituitary and Related Disorders (RAPID) database, which encompassed patients from 14 participating institutions across the United States between 2000 and 2024. The database was screened for adult patients who underwent initial CP treatment with a confirmed histopathological diagnosis of ACP or PCP. Patient demographic characteristics, clinical course, tumor treatment, and outcomes data were collected and compared by CP type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The final analysis included 273 ACP and 99 PCP adult patients who underwent initial surgical treatment. ACP patients presented younger on average (mean 48.3 vs 52.8 years, p = 0.034). PCP patients were more likely to present with hypothyroidism (33.3% vs 20.5%, p = 0.010), hyperlipidemia (25.3% vs 15.8%, p = 0.036), fatigue (28.3% vs 17.6%, p = 0.024), temperature intolerance (9.1% vs 1.5%, p &lt; 0.001), and cardiac arrhythmia (6.1% vs 1.1%, p = 0.006). The groups demonstrated similar postsurgical and neuroendocrinological outcomes. Postoperative median (IQR) progression-free survival did not significantly differ between groups (19.0 [7.0\u201337.0] for ACP vs 5.0 [3.5\u20137.5] months for PCP, p = 0.972). ACP patients were more likely to receive radiation after surgery (27.8% vs 15.2%, p = 0.012).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>This large multicenter descriptive study aimed to characterize similarities and differences between the clinical courses of molecularly distinct ACP and PCP, which has not previously been described. The findings should serve as a baseline to inform future studies, particularly with the recent introduction of targeted therapy for PCP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2026.2.focus251172","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:01:01Z","timestamp":1779840061000},"page":"E11","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of clinical outcomes in adamantinomatous and papillary craniopharyngioma: a baseline analysis before the targeted therapy era"],"prefix":"10.3171","volume":"60","author":[{"given":"Mark A.","family":"Damante","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan B.","family":"Juncker","sequence":"additional","affiliation":[{"name":"College of Medicine, The Ohio State University, Columbus, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garni","family":"Barkhoudarian","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Pacific Neuroscience Institute, Providence St. Johns Medical Center, Santa Monica;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Fernandez-Miranda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University, Palo Alto, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato R.","family":"Pacione","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, New York University, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Chicoine","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Missouri, Columbia, Missouri;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Zada","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun R.","family":"Kshettry","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Miller School of Medicine, University of Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Van Gompel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Catalino","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Virginia, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mamelak","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Zwagerman","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Little","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pacult","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gardner","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Karsy","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Couldwell","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Utah, Salt Lake City, Utah; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Rennert","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Utah, Salt Lake City, Utah; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Prevedello","sequence":"additional","affiliation":[{"name":"College of Medicine, The Ohio State University, Columbus, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle C.","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Medicine, The Ohio State University, Columbus, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"5","key":"b1","series-title":"Neuro Oncol","first-page":"1180","article-title":"Molecular subtypes of adamantinomatous craniopharyngiomas","volume":"27","author":"An W","year":"2025","unstructured":"An W, Li S, An Y, Lin Z. Molecular subtypes of adamantinomatous craniopharyngiomas. Neuro Oncol. 2025;27(5):1180\u20131192. doi:10.1093\/neuonc\/noaf030"},{"issue":"3","key":"b2","series-title":"Endocr Rev","first-page":"518","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps JR","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP. Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev. 2023;44(3):518\u2013538. doi:10.1210\/endrev\/bnac035"},{"issue":"1","key":"b3","series-title":"J Neurooncol","first-page":"225","article-title":"Papillary craniopharyngioma management in the era of BRAF and MEK inhibition","volume":"173","author":"Damante M","year":"2025","unstructured":"Damante M, Cua S, Kreatsoulas D,  Papillary craniopharyngioma management in the era of BRAF and MEK inhibition. J Neurooncol. 2025;173(1):225\u2013232. doi:10.1007\/s11060-025-04969-3"},{"issue":"1","key":"b4","series-title":"Nat Rev Dis Primers","first-page":"75","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller HL","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019;5(1):75. doi:10.1038\/s41572-019-0125-9"},{"issue":"5","key":"b5","series-title":"J Neurosurg","first-page":"1293","article-title":"Editorial. Craniopharyngioma classification","volume":"135","author":"Magill ST","year":"2021","unstructured":"Magill ST, Jane JA, Prevedello DM. Editorial. Craniopharyngioma classification. J Neurosurg. 2021;135(5):1293\u20131295. doi:10.3171\/2020.8.JNS202666"},{"key":"b6","series-title":"Front Surg","first-page":"1073736","article-title":"Ultrasound-guided endoscopic endonasal resection of sellar and suprasellar craniopharyngiomas","volume":"10","author":"Finger G","year":"2023","unstructured":"Finger G, Wu KC, Godil SS, Carrau RL, Hardesty D, Prevedello DM. Ultrasound-guided endoscopic endonasal resection of sellar and suprasellar craniopharyngiomas. Front Surg. 2023;10:1073736. doi:10.3389\/fsurg.2023.1073736"},{"key":"b7","series-title":"Front Oncol","first-page":"1058329","article-title":"Craniopharyngioma resection by endoscopic endonasal approach versus transcranial approach: a systematic review and meta-analysis of comparative studies","volume":"12","author":"Na MK","year":"2022","unstructured":"Na MK, Jang B, Choi KS,  Craniopharyngioma resection by endoscopic endonasal approach versus transcranial approach: a systematic review and meta-analysis of comparative studies. Front Oncol. 2022;12:1058329. doi:10.3389\/fonc.2022.1058329"},{"issue":"2","key":"b8","series-title":"Nat Genet","first-page":"161","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos PK","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE,  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161\u2013165. doi:10.1038\/ng.2868"},{"issue":"2","key":"b9","series-title":"N Engl J Med","first-page":"118","article-title":"BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos PK","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S,  BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023;389(2):118\u2013126. doi:10.1056\/NEJMoa2213329"},{"issue":"7","key":"b10","series-title":"Cancers (Basel)","first-page":"1823","article-title":"BRAF inhibitors: molecular targeting and immunomodulatory actions","volume":"12","author":"Proietti I","year":"2020","unstructured":"Proietti I, Skroza N, Michelini S,  BRAF inhibitors: molecular targeting and immunomodulatory actions. Cancers (Basel). 2020;12(7):1823. doi:10.3390\/cancers12071823"},{"issue":"5","key":"b11","series-title":"Neuroradiology","first-page":"1313","article-title":"Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction","volume":"67","author":"Calandrelli R","year":"2025","unstructured":"Calandrelli R, Pilato F, D\u2019Apolito G,  Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction. Neuroradiology. 2025;67(5):1313\u20131327. doi:10.1007\/s00234-025-03615-z"},{"key":"b12","series-title":"Neoplasia","first-page":"101060","article-title":"Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes","volume":"57","author":"Yang L","year":"2024","unstructured":"Yang L, Liu Y, Wang C,  Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes. Neoplasia. 2024;57:101060. doi:10.1016\/j.neo.2024.101060"},{"issue":"2","key":"b13","series-title":"Neurosurgery","first-page":"372","article-title":"Multicenter Registry of Adenomas of the Pituitary and Related Disorders: initial description of Cushing disease cohort, surgical outcomes, and surgeon characteristics","volume":"95","author":"Little AS","year":"2024","unstructured":"Little AS, Karsy M, Evans JJ,  Multicenter Registry of Adenomas of the Pituitary and Related Disorders: initial description of Cushing disease cohort, surgical outcomes, and surgeon characteristics. Neurosurgery. 2024;95(2):372\u2013379. doi:10.1227\/neu.0000000000002888"},{"issue":"1","key":"b14","series-title":"Neurosurg Rev","first-page":"139","article-title":"Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis","volume":"45","author":"Wu J","year":"2022","unstructured":"Wu J, Wu X, Yang YQ,  Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis. Neurosurg Rev. 2022;45(1):139\u2013150. doi:10.1007\/s10143-021-01563-9"},{"issue":"2","key":"b15","series-title":"J Neurooncol","first-page":"343","article-title":"Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020","volume":"173","author":"Agner KE","year":"2025","unstructured":"Agner KE, Larkins MC. Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020. J Neurooncol. 2025;173(2):343\u2013351. doi:10.1007\/s11060-025-04988-0"},{"issue":"6","key":"b16","series-title":"Neurosurgery","first-page":"1112","article-title":"Characteristics and outcomes in pediatric versus adult craniopharyngiomas: a systematic review and meta-analysis","volume":"92","author":"Pang JC","year":"2023","unstructured":"Pang JC, Chung DD, Wang J,  Characteristics and outcomes in pediatric versus adult craniopharyngiomas: a systematic review and meta-analysis. Neurosurgery. 2023;92(6):1112\u20131129. doi:10.1227\/neu.0000000000002346"},{"key":"b17","series-title":"Adv Exp Med Biol","first-page":"299","article-title":"Craniopharyngioma in pediatrics and adults","volume":"1405","author":"Piloni M","year":"2023","unstructured":"Piloni M, Gagliardi F, Bailo M,  Craniopharyngioma in pediatrics and adults. Adv Exp Med Biol. 2023;1405:299\u2013329."},{"issue":"11","key":"b18","series-title":"J Clin Endocrinol Metab","first-page":"3897","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence","volume":"83","author":"B\u00fclow B","year":"1998","unstructured":"B\u00fclow B, Attewell R, Hagmar L, Malmstr\u00f6m P, Nordstr\u00f6m CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab. 1998;83(11):3897\u20133904. doi:10.1210\/jcem.83.11.5240"},{"issue":"1","key":"b19","series-title":"Eur J Endocrinol","first-page":"93","article-title":"Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study","volume":"178","author":"Wijnen M","year":"2018","unstructured":"Wijnen M, Olsson DS, van den Heuvel-Eibrink MM,  Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol. 2018;178(1):93\u2013102. doi:10.1530\/EJE-17-0707"},{"issue":"2","key":"b20","series-title":"J Clin Endocrinol Metab","first-page":"467","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson DS","year":"2015","unstructured":"Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab. 2015;100(2):467\u2013474. doi:10.1210\/jc.2014-3525"},{"key":"b21","series-title":"Front Endocrinol (Lausanne)","first-page":"1180591","article-title":"Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma","volume":"14","author":"Guo Y","year":"2023","unstructured":"Guo Y, Pei L, Li Y,  Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma. Front Endocrinol (Lausanne). 2023;14:1180591. doi:10.3389\/fendo.2023.1180591"},{"key":"b22","series-title":"Front Endocrinol (Lausanne)","first-page":"1615720","article-title":"Characteristics and influencing factors of neuroendocrine dysfunction in patients with adult-onset craniopharyngioma","volume":"16","author":"Guo Y","year":"2025","unstructured":"Guo Y, Gui S, Liu P, Zhang Y, Zhong L, Xu J. Characteristics and influencing factors of neuroendocrine dysfunction in patients with adult-onset craniopharyngioma. Front Endocrinol (Lausanne). 2025;16:1615720. doi:10.3389\/fendo.2025.1615720"},{"issue":"5","key":"b23","series-title":"Best Pract Res Clin Endocrinol Metab","first-page":"101999","article-title":"Metabolic complications and their mechanisms in patients with craniopharyngioma","volume":"39","author":"Erfurth EM","year":"2025","unstructured":"Erfurth EM, M\u00fcller HL. Metabolic complications and their mechanisms in patients with craniopharyngioma. Best Pract Res Clin Endocrinol Metab. 2025;39(5):101999. doi:10.1016\/j.beem.2025.101999"},{"issue":"778","key":"b24","series-title":"Sci Transl Med","first-page":"eadn6763","article-title":"Modeling craniopharyngioma for drug screening reveals a neuronal mechanism for tumor growth","volume":"16","author":"Li S","year":"2024","unstructured":"Li S, Li W, Miao Y,  Modeling craniopharyngioma for drug screening reveals a neuronal mechanism for tumor growth. Sci Transl Med. 2024;16(778):eadn6763. doi:10.1126\/scitranslmed.adn6763"},{"key":"b25","series-title":"World Neurosurg","first-page":"e656","article-title":"Endocrine and visual outcomes following gross total resection and subtotal resection of adult craniopharyngioma: systematic review and meta-analysis","volume":"127","author":"Akinduro OO","year":"2019","unstructured":"Akinduro OO, Izzo A, Lu VM,  Endocrine and visual outcomes following gross total resection and subtotal resection of adult craniopharyngioma: systematic review and meta-analysis. World Neurosurg. 2019;127:e656\u2013e668. doi:10.1016\/j.wneu.2019.03.239"},{"issue":"4","key":"b26","series-title":"J Neurosurg","first-page":"1163","article-title":"Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas","volume":"131","author":"Ord\u00f3\u00f1ez-Rubiano EG","year":"2019","unstructured":"Ord\u00f3\u00f1ez-Rubiano EG, Forbes JA, Morgenstern PF,  Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas. J Neurosurg. 2019;131(4):1163\u20131171. doi:10.3171\/2018.6.JNS18901"},{"issue":"15","key":"b27","series-title":"Cancers (Basel)","first-page":"2516","article-title":"Comparative outcomes of gross total resection vs. subtotal resection plus radiotherapy for preventing craniopharyngioma recurrence: a meta-analysis of the endoscopic endonasal approach","volume":"17","author":"Bobeff EJ","year":"2025","unstructured":"Bobeff EJ, Szmyd B, M\u0142ynarski W,  Comparative outcomes of gross total resection vs. subtotal resection plus radiotherapy for preventing craniopharyngioma recurrence: a meta-analysis of the endoscopic endonasal approach. Cancers (Basel). 2025;17(15):2516. doi:10.3390\/cancers17152516"},{"issue":"5","key":"b28","series-title":"J Neurosurg","first-page":"1235","article-title":"Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma","volume":"139","author":"Bobeff EJ","year":"2023","unstructured":"Bobeff EJ, Mathios D, Mistry AA,  Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma. J Neurosurg. 2023;139(5):1235\u20131246. doi:10.3171\/2023.3.JNS222607"},{"issue":"5","key":"b29","series-title":"J Neurosurg","first-page":"1347","article-title":"Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy","volume":"136","author":"Godil SS","year":"2022","unstructured":"Godil SS, Tosi U, Gerges M,  Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy. J Neurosurg. 2022;136(5):1347\u20131355. doi:10.3171\/2021.5.JNS202011"},{"issue":"2","key":"b30","series-title":"J Neurooncol","first-page":"275","article-title":"The spectrum of radiation therapy options for craniopharyngioma: a systematic review","volume":"173","author":"Harary PM","year":"2025","unstructured":"Harary PM, Rajaram S, Hori YS, Park DJ, Chang SD. The spectrum of radiation therapy options for craniopharyngioma: a systematic review. J Neurooncol. 2025;173(2):275\u2013288. doi:10.1007\/s11060-025-05001-4"},{"issue":"5","key":"b31","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1011","article-title":"Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience","volume":"88","author":"Lo AC","year":"2014","unstructured":"Lo AC, Howard AF, Nichol A,  Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2014;88(5):1011\u20131018. doi:10.1016\/j.ijrobp.2014.01.019"},{"key":"b32","series-title":"World Neurosurg","first-page":"e809","article-title":"Patterns of care in craniopharyngioma: clinical outcomes after surgery and radiation therapy in a real-world setting","volume":"181","author":"Ghosh S","year":"2024","unstructured":"Ghosh S, Goda JS, Chatterjee A,  Patterns of care in craniopharyngioma: clinical outcomes after surgery and radiation therapy in a real-world setting. World Neurosurg. 2024;181:e809\u2013e819. doi:10.1016\/j.wneu.2023.10.138"},{"issue":"12","key":"b33","series-title":"Thyroid","first-page":"1200","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber JR","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H,  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200\u20131235. doi:10.1089\/thy.2012.0205"},{"issue":"5","key":"b34","series-title":"Pituitary","first-page":"103","article-title":"Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis","volume":"28","author":"Pan LS","year":"2025","unstructured":"Pan LS, Zhang J, Xiong YT, Zhan JB, Wang QY, Hong T. Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis. Pituitary. 2025;28(5):103. doi:10.1007\/s11102-025-01578-1"},{"issue":"4","key":"b35","series-title":"Neuro Oncol","first-page":"710","article-title":"Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients","volume":"25","author":"Beddok A","year":"2023","unstructured":"Beddok A, Scher N, Alapetite C,  Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients. Neuro Oncol. 2023;25(4):710\u2013719. doi:10.1093\/neuonc\/noac210"},{"issue":"2","key":"b36","series-title":"J Natl Cancer Inst","first-page":"djv310","article-title":"Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy","volume":"108","author":"Brastianos PK","year":"2016","unstructured":"Brastianos PK, Shankar GM, Gill CM,  Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst. 2016;108(2):djv310. doi:10.1093\/jnci\/djv310"},{"issue":"Supplement_5","key":"b37","series-title":"Neuro Oncol","first-page":"v127","article-title":"CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients","volume":"27","author":"Papadopoulos KP","year":"2025","unstructured":"Papadopoulos KP, Brastianos PK, Cecchini M,  CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients. Neuro Oncol. 2025;27(Supplement_5):v127. doi:10.1093\/neuonc\/noaf201.0507"},{"issue":"5","key":"b38","series-title":"Best Pract Res Clin Endocrinol Metab","first-page":"102051","article-title":"Decoding craniopharyngioma: from mechanisms to therapy","volume":"39","author":"Gonzalez-Meljem JM","year":"2025","unstructured":"Gonzalez-Meljem JM, Cao L, Apps JR, Martinez-Barbera JP. Decoding craniopharyngioma: from mechanisms to therapy. Best Pract Res Clin Endocrinol Metab. 2025;39(5):102051. doi:10.1016\/j.beem.2025.102051"},{"issue":"4","key":"b39","series-title":"Endocrinol Metab Clin North Am","first-page":"703","article-title":"Pathogenesis of craniopharyngiomas and targeted approaches to therapy","volume":"54","author":"Gritsch S","year":"2025","unstructured":"Gritsch S, Brastianos PK. Pathogenesis of craniopharyngiomas and targeted approaches to therapy. Endocrinol Metab Clin North Am. 2025;54(4):703\u2013714. doi:10.1016\/j.ecl.2025.06.006"},{"issue":"5","key":"b1","series-title":"Neuro Oncol","first-page":"1180","article-title":"Molecular subtypes of adamantinomatous craniopharyngiomas","volume":"27","author":"An W","year":"2025","unstructured":"An W, Li S, An Y, Lin Z. Molecular subtypes of adamantinomatous craniopharyngiomas. Neuro Oncol. 2025;27(5):1180\u20131192. doi:10.1093\/neuonc\/noaf030"},{"issue":"3","key":"b2","series-title":"Endocr Rev","first-page":"518","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps JR","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP. Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev. 2023;44(3):518\u2013538. doi:10.1210\/endrev\/bnac035"},{"issue":"1","key":"b3","series-title":"J Neurooncol","first-page":"225","article-title":"Papillary craniopharyngioma management in the era of BRAF and MEK inhibition","volume":"173","author":"Damante M","year":"2025","unstructured":"Damante M, Cua S, Kreatsoulas D,  Papillary craniopharyngioma management in the era of BRAF and MEK inhibition. J Neurooncol. 2025;173(1):225\u2013232. doi:10.1007\/s11060-025-04969-3"},{"issue":"1","key":"b4","series-title":"Nat Rev Dis Primers","first-page":"75","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller HL","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019;5(1):75. doi:10.1038\/s41572-019-0125-9"},{"issue":"5","key":"b5","series-title":"J Neurosurg","first-page":"1293","article-title":"Editorial. Craniopharyngioma classification","volume":"135","author":"Magill ST","year":"2021","unstructured":"Magill ST, Jane JA, Prevedello DM. Editorial. Craniopharyngioma classification. J Neurosurg. 2021;135(5):1293\u20131295. doi:10.3171\/2020.8.JNS202666"},{"key":"b6","series-title":"Front Surg","first-page":"1073736","article-title":"Ultrasound-guided endoscopic endonasal resection of sellar and suprasellar craniopharyngiomas","volume":"10","author":"Finger G","year":"2023","unstructured":"Finger G, Wu KC, Godil SS, Carrau RL, Hardesty D, Prevedello DM. Ultrasound-guided endoscopic endonasal resection of sellar and suprasellar craniopharyngiomas. Front Surg. 2023;10:1073736. doi:10.3389\/fsurg.2023.1073736"},{"key":"b7","series-title":"Front Oncol","first-page":"1058329","article-title":"Craniopharyngioma resection by endoscopic endonasal approach versus transcranial approach: a systematic review and meta-analysis of comparative studies","volume":"12","author":"Na MK","year":"2022","unstructured":"Na MK, Jang B, Choi KS,  Craniopharyngioma resection by endoscopic endonasal approach versus transcranial approach: a systematic review and meta-analysis of comparative studies. Front Oncol. 2022;12:1058329. doi:10.3389\/fonc.2022.1058329"},{"issue":"2","key":"b8","series-title":"Nat Genet","first-page":"161","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos PK","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE,  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161\u2013165. doi:10.1038\/ng.2868"},{"issue":"2","key":"b9","series-title":"N Engl J Med","first-page":"118","article-title":"BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos PK","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S,  BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023;389(2):118\u2013126. doi:10.1056\/NEJMoa2213329"},{"issue":"7","key":"b10","series-title":"Cancers (Basel)","first-page":"1823","article-title":"BRAF inhibitors: molecular targeting and immunomodulatory actions","volume":"12","author":"Proietti I","year":"2020","unstructured":"Proietti I, Skroza N, Michelini S,  BRAF inhibitors: molecular targeting and immunomodulatory actions. Cancers (Basel). 2020;12(7):1823. doi:10.3390\/cancers12071823"},{"issue":"5","key":"b11","series-title":"Neuroradiology","first-page":"1313","article-title":"Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction","volume":"67","author":"Calandrelli R","year":"2025","unstructured":"Calandrelli R, Pilato F, D\u2019Apolito G,  Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction. Neuroradiology. 2025;67(5):1313\u20131327. doi:10.1007\/s00234-025-03615-z"},{"key":"b12","series-title":"Neoplasia","first-page":"101060","article-title":"Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes","volume":"57","author":"Yang L","year":"2024","unstructured":"Yang L, Liu Y, Wang C,  Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes. Neoplasia. 2024;57:101060. doi:10.1016\/j.neo.2024.101060"},{"issue":"2","key":"b13","series-title":"Neurosurgery","first-page":"372","article-title":"Multicenter Registry of Adenomas of the Pituitary and Related Disorders: initial description of Cushing disease cohort, surgical outcomes, and surgeon characteristics","volume":"95","author":"Little AS","year":"2024","unstructured":"Little AS, Karsy M, Evans JJ,  Multicenter Registry of Adenomas of the Pituitary and Related Disorders: initial description of Cushing disease cohort, surgical outcomes, and surgeon characteristics. Neurosurgery. 2024;95(2):372\u2013379. doi:10.1227\/neu.0000000000002888"},{"issue":"1","key":"b14","series-title":"Neurosurg Rev","first-page":"139","article-title":"Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis","volume":"45","author":"Wu J","year":"2022","unstructured":"Wu J, Wu X, Yang YQ,  Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis. Neurosurg Rev. 2022;45(1):139\u2013150. doi:10.1007\/s10143-021-01563-9"},{"issue":"2","key":"b15","series-title":"J Neurooncol","first-page":"343","article-title":"Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020","volume":"173","author":"Agner KE","year":"2025","unstructured":"Agner KE, Larkins MC. Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020. J Neurooncol. 2025;173(2):343\u2013351. doi:10.1007\/s11060-025-04988-0"},{"issue":"6","key":"b16","series-title":"Neurosurgery","first-page":"1112","article-title":"Characteristics and outcomes in pediatric versus adult craniopharyngiomas: a systematic review and meta-analysis","volume":"92","author":"Pang JC","year":"2023","unstructured":"Pang JC, Chung DD, Wang J,  Characteristics and outcomes in pediatric versus adult craniopharyngiomas: a systematic review and meta-analysis. Neurosurgery. 2023;92(6):1112\u20131129. doi:10.1227\/neu.0000000000002346"},{"key":"b17","series-title":"Adv Exp Med Biol","first-page":"299","article-title":"Craniopharyngioma in pediatrics and adults","volume":"1405","author":"Piloni M","year":"2023","unstructured":"Piloni M, Gagliardi F, Bailo M,  Craniopharyngioma in pediatrics and adults. Adv Exp Med Biol. 2023;1405:299\u2013329."},{"issue":"11","key":"b18","series-title":"J Clin Endocrinol Metab","first-page":"3897","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence","volume":"83","author":"B\u00fclow B","year":"1998","unstructured":"B\u00fclow B, Attewell R, Hagmar L, Malmstr\u00f6m P, Nordstr\u00f6m CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab. 1998;83(11):3897\u20133904. doi:10.1210\/jcem.83.11.5240"},{"issue":"1","key":"b19","series-title":"Eur J Endocrinol","first-page":"93","article-title":"Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study","volume":"178","author":"Wijnen M","year":"2018","unstructured":"Wijnen M, Olsson DS, van den Heuvel-Eibrink MM,  Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol. 2018;178(1):93\u2013102. doi:10.1530\/EJE-17-0707"},{"issue":"2","key":"b20","series-title":"J Clin Endocrinol Metab","first-page":"467","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson DS","year":"2015","unstructured":"Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab. 2015;100(2):467\u2013474. doi:10.1210\/jc.2014-3525"},{"key":"b21","series-title":"Front Endocrinol (Lausanne)","first-page":"1180591","article-title":"Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma","volume":"14","author":"Guo Y","year":"2023","unstructured":"Guo Y, Pei L, Li Y,  Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma. Front Endocrinol (Lausanne). 2023;14:1180591. doi:10.3389\/fendo.2023.1180591"},{"key":"b22","series-title":"Front Endocrinol (Lausanne)","first-page":"1615720","article-title":"Characteristics and influencing factors of neuroendocrine dysfunction in patients with adult-onset craniopharyngioma","volume":"16","author":"Guo Y","year":"2025","unstructured":"Guo Y, Gui S, Liu P, Zhang Y, Zhong L, Xu J. Characteristics and influencing factors of neuroendocrine dysfunction in patients with adult-onset craniopharyngioma. Front Endocrinol (Lausanne). 2025;16:1615720. doi:10.3389\/fendo.2025.1615720"},{"issue":"5","key":"b23","series-title":"Best Pract Res Clin Endocrinol Metab","first-page":"101999","article-title":"Metabolic complications and their mechanisms in patients with craniopharyngioma","volume":"39","author":"Erfurth EM","year":"2025","unstructured":"Erfurth EM, M\u00fcller HL. Metabolic complications and their mechanisms in patients with craniopharyngioma. Best Pract Res Clin Endocrinol Metab. 2025;39(5):101999. doi:10.1016\/j.beem.2025.101999"},{"issue":"778","key":"b24","series-title":"Sci Transl Med","first-page":"eadn6763","article-title":"Modeling craniopharyngioma for drug screening reveals a neuronal mechanism for tumor growth","volume":"16","author":"Li S","year":"2024","unstructured":"Li S, Li W, Miao Y,  Modeling craniopharyngioma for drug screening reveals a neuronal mechanism for tumor growth. Sci Transl Med. 2024;16(778):eadn6763. doi:10.1126\/scitranslmed.adn6763"},{"key":"b25","series-title":"World Neurosurg","first-page":"e656","article-title":"Endocrine and visual outcomes following gross total resection and subtotal resection of adult craniopharyngioma: systematic review and meta-analysis","volume":"127","author":"Akinduro OO","year":"2019","unstructured":"Akinduro OO, Izzo A, Lu VM,  Endocrine and visual outcomes following gross total resection and subtotal resection of adult craniopharyngioma: systematic review and meta-analysis. World Neurosurg. 2019;127:e656\u2013e668. doi:10.1016\/j.wneu.2019.03.239"},{"issue":"4","key":"b26","series-title":"J Neurosurg","first-page":"1163","article-title":"Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas","volume":"131","author":"Ord\u00f3\u00f1ez-Rubiano EG","year":"2019","unstructured":"Ord\u00f3\u00f1ez-Rubiano EG, Forbes JA, Morgenstern PF,  Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas. J Neurosurg. 2019;131(4):1163\u20131171. doi:10.3171\/2018.6.JNS18901"},{"issue":"15","key":"b27","series-title":"Cancers (Basel)","first-page":"2516","article-title":"Comparative outcomes of gross total resection vs. subtotal resection plus radiotherapy for preventing craniopharyngioma recurrence: a meta-analysis of the endoscopic endonasal approach","volume":"17","author":"Bobeff EJ","year":"2025","unstructured":"Bobeff EJ, Szmyd B, M\u0142ynarski W,  Comparative outcomes of gross total resection vs. subtotal resection plus radiotherapy for preventing craniopharyngioma recurrence: a meta-analysis of the endoscopic endonasal approach. Cancers (Basel). 2025;17(15):2516. doi:10.3390\/cancers17152516"},{"issue":"5","key":"b28","series-title":"J Neurosurg","first-page":"1235","article-title":"Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma","volume":"139","author":"Bobeff EJ","year":"2023","unstructured":"Bobeff EJ, Mathios D, Mistry AA,  Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma. J Neurosurg. 2023;139(5):1235\u20131246. doi:10.3171\/2023.3.JNS222607"},{"issue":"5","key":"b29","series-title":"J Neurosurg","first-page":"1347","article-title":"Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy","volume":"136","author":"Godil SS","year":"2022","unstructured":"Godil SS, Tosi U, Gerges M,  Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy. J Neurosurg. 2022;136(5):1347\u20131355. doi:10.3171\/2021.5.JNS202011"},{"issue":"2","key":"b30","series-title":"J Neurooncol","first-page":"275","article-title":"The spectrum of radiation therapy options for craniopharyngioma: a systematic review","volume":"173","author":"Harary PM","year":"2025","unstructured":"Harary PM, Rajaram S, Hori YS, Park DJ, Chang SD. The spectrum of radiation therapy options for craniopharyngioma: a systematic review. J Neurooncol. 2025;173(2):275\u2013288. doi:10.1007\/s11060-025-05001-4"},{"issue":"5","key":"b31","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1011","article-title":"Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience","volume":"88","author":"Lo AC","year":"2014","unstructured":"Lo AC, Howard AF, Nichol A,  Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2014;88(5):1011\u20131018. doi:10.1016\/j.ijrobp.2014.01.019"},{"key":"b32","series-title":"World Neurosurg","first-page":"e809","article-title":"Patterns of care in craniopharyngioma: clinical outcomes after surgery and radiation therapy in a real-world setting","volume":"181","author":"Ghosh S","year":"2024","unstructured":"Ghosh S, Goda JS, Chatterjee A,  Patterns of care in craniopharyngioma: clinical outcomes after surgery and radiation therapy in a real-world setting. World Neurosurg. 2024;181:e809\u2013e819. doi:10.1016\/j.wneu.2023.10.138"},{"issue":"12","key":"b33","series-title":"Thyroid","first-page":"1200","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber JR","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H,  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200\u20131235. doi:10.1089\/thy.2012.0205"},{"issue":"5","key":"b34","series-title":"Pituitary","first-page":"103","article-title":"Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis","volume":"28","author":"Pan LS","year":"2025","unstructured":"Pan LS, Zhang J, Xiong YT, Zhan JB, Wang QY, Hong T. Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis. Pituitary. 2025;28(5):103. doi:10.1007\/s11102-025-01578-1"},{"issue":"4","key":"b35","series-title":"Neuro Oncol","first-page":"710","article-title":"Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients","volume":"25","author":"Beddok A","year":"2023","unstructured":"Beddok A, Scher N, Alapetite C,  Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients. Neuro Oncol. 2023;25(4):710\u2013719. doi:10.1093\/neuonc\/noac210"},{"issue":"2","key":"b36","series-title":"J Natl Cancer Inst","first-page":"djv310","article-title":"Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy","volume":"108","author":"Brastianos PK","year":"2016","unstructured":"Brastianos PK, Shankar GM, Gill CM,  Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst. 2016;108(2):djv310. doi:10.1093\/jnci\/djv310"},{"issue":"Supplement_5","key":"b37","series-title":"Neuro Oncol","first-page":"v127","article-title":"CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients","volume":"27","author":"Papadopoulos KP","year":"2025","unstructured":"Papadopoulos KP, Brastianos PK, Cecchini M,  CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients. Neuro Oncol. 2025;27(Supplement_5):v127. doi:10.1093\/neuonc\/noaf201.0507"},{"issue":"5","key":"b38","series-title":"Best Pract Res Clin Endocrinol Metab","first-page":"102051","article-title":"Decoding craniopharyngioma: from mechanisms to therapy","volume":"39","author":"Gonzalez-Meljem JM","year":"2025","unstructured":"Gonzalez-Meljem JM, Cao L, Apps JR, Martinez-Barbera JP. Decoding craniopharyngioma: from mechanisms to therapy. Best Pract Res Clin Endocrinol Metab. 2025;39(5):102051. doi:10.1016\/j.beem.2025.102051"},{"issue":"4","key":"b39","series-title":"Endocrinol Metab Clin North Am","first-page":"703","article-title":"Pathogenesis of craniopharyngiomas and targeted approaches to therapy","volume":"54","author":"Gritsch S","year":"2025","unstructured":"Gritsch S, Brastianos PK. Pathogenesis of craniopharyngiomas and targeted approaches to therapy. Endocrinol Metab Clin North Am. 2025;54(4):703\u2013714. doi:10.1016\/j.ecl.2025.06.006"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/6\/article-pE11.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/6\/article-pE11.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/6\/article-pE11.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:35Z","timestamp":1780444835000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/6\/article-pE11.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":78,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2026.2.focus251172","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}